AAAAAA
Results: 51-67/67
Authors:
Wagner, T
Stoppa-Lyonnet, D
Fleischmann, E
Muhr, D
Pages, S
Sandberg, T
Caux, V
Moeslinger, R
Langbauer, G
Borg, A
Oefner, P
Citation: T. Wagner et al., Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations, GENOMICS, 62(3), 1999, pp. 369-376
Authors:
Borg, A
Dorum, A
Heimdal, K
Maehle, L
Hovig, E
Moller, P
Citation: A. Borg et al., BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations, DIS MARKER, 15(1-3), 1999, pp. 79-84
Authors:
Bergthorsson, JT
Winther, K
Fenger, K
Niebuhr, A
Klausen, S
Borg, A
Harboe, T
Ejlertsen, B
Niebuhr, E
Citation: Jt. Bergthorsson et al., Mutations of the BRCA1 and BRCA2 genes in Danish patients diagnosed at young age with multi-centric or bilateral breast cancer, DIS MARKER, 15(1-3), 1999, pp. 94-94
Authors:
Moller, P
Borg, A
Evans, G
Haites, N
Steel, CM
Vasen, H
Gregory, H
Hodgson, S
Apold, J
Lalloo, F
Maehle, L
Anderson, E
Heimdal, K
Citation: P. Moller et al., Mutation-specific survival of inherited breast cancer, DIS MARKER, 15(1-3), 1999, pp. 205-205
Authors:
Moller, P
Evans, G
Haites, N
Vasen, H
Reis, MM
Anderson, E
Apold, J
Hodgson, S
Eccles, D
Olsson, H
Stoppa-Lyonnet, D
Chang-Claude, J
Morrison, PJ
Bevilacqua, G
Heimdal, K
Maehle, L
Lalloo, F
Gregory, H
Preece, P
Borg, A
Nevin, NC
Caligo, M
Steel, CM
Citation: P. Moller et al., Guidelines for follow-up of women at high risk for inherited breast cancer: Consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer, DIS MARKER, 15(1-3), 1999, pp. 207-211
Authors:
Worren, T
Ramsvik, T
Borg, A
Citation: T. Worren et al., Homoepitaxial growth of Co on Co(11(2)over-bar-0) studied by STM, APPL SURF S, 142(1-4), 1999, pp. 48-51
Authors:
Jernstrom, HCB
Johannsson, OT
Loman, N
Borg, A
Olsson, H
Citation: Hcb. Jernstrom et al., Reproductive factors in hereditary breast cancer, BREAST CANC, 58(3), 1999, pp. 295-301
Authors:
Ramstad, A
Strisland, F
Raaen, S
Borg, A
Berg, C
Citation: A. Ramstad et al., CO and O-2 adsorption on the Re/Pt(111) surface studied by photoemission and thermal desorption., SURF SCI, 440(1-2), 1999, pp. 290-300
Authors:
Ramstad, A
Strisland, F
Raaen, S
Worren, T
Borg, A
Berg, C
Citation: A. Ramstad et al., Growth and alloy formation studied by photoelectron spectroscopy and STM, SURF SCI, 425(1), 1999, pp. 57-67
Authors:
Planck, M
Koul, A
Fernebro, E
Borg, A
Kristoffersson, U
Olsson, H
Wenngren, E
Mangell, P
Nilbert, M
Citation: M. Planck et al., hMLH1, hMSH2 and hMSH6 mutations in hereditary non-polyposis colorectal cancer families from Southern Sweden, INT J CANC, 83(2), 1999, pp. 197-202
Authors:
Loman, N
Johannsson, O
Bendahl, PO
Borg, A
Ferno, M
Olsson, H
Citation: N. Loman et al., Steroid receptors in hereditary breast carcinomas associated with BRCA1 orBRCA2 mutations or unknown susceptibility genes - Reply, CANCER, 85(10), 1999, pp. 2293-2295
Authors:
Bratt, O
Borg, A
Kristoffersson, U
Lundgren, R
Zhang, QX
Olsson, H
Citation: O. Bratt et al., CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk, BR J CANC, 81(4), 1999, pp. 672-676
Authors:
Launonen, V
Laake, K
Huusko, P
Niederacher, D
Beckmann, MW
Barkardottir, RB
Geirsdottir, EK
Gudmundsson, J
Rio, P
Bignon, YJ
Seitz, S
Scherneck, S
Bieche, I
Champeme, MH
Birnbaum, D
White, G
Varley, J
Sztan, M
Olah, E
Osorio, A
Benitez, J
Spurr, N
Velikonja, N
Peterlin, B
Borg, A
Cleton-Jansen, AM
Devilee, P
Bloigu, R
Lidereau, R
Borresen-Dale, AL
Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882
Authors:
Fioretos, T
Strombeck, B
Sandberg, T
Johansson, B
Billstrom, R
Borg, A
Nilsson, PG
Van Den Berghe, H
Hagemeijer, A
Mitelman, F
Hoglund, M
Citation: T. Fioretos et al., Isochromosome 17q in blast crisis of chronic myeloid leukemia and in otherhematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations, BLOOD, 94(1), 1999, pp. 225-232
Authors:
Koul, A
Malander, S
Ridderheim, M
Borg, A
Citation: A. Koul et al., BRCA1 and BRCA2 mutations in ovarian cancer: covariation with specific cytogenetic features, 7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, pp. 243-246
Authors:
Jernstrom, H
Johannsson, O
Borg, A
Olsson, H
Citation: H. Jernstrom et al., Do BRCA1 mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCA1 mutation carriers compared with their unaffected relatives, BREAST, 7(6), 1998, pp. 320-324
Authors:
Devilee, P
Barkardottir, RB
Bevilacqua, G
Bignon, YJ
Bishop, T
Borg, A
Borresen-Dale, AL
Chang-Claude, J
Easton, D
Eyfjord, J
Feunteun, J
Goldgar, D
Haites, N
Holm, N
Kruse, T
Larsson, C
Lenoir, G
Lidereau, R
Nevanlinna, H
Ponder, B
Scherneck, S
Schmitt, F
Sobol, H
Solomon, E
Spurr, N
Steel, M
Stratton, M
Varley, J
Vasen, H
Vassilaros, S
Wagner, T
Willems, P
Winqvist, R
Citation: P. Devilee et al., Genetics and epidemiology of hereditary breast cancer, BIOM HLTH R, 24, 1998, pp. 339-346